Peer-reviewedCC BY 4.0Trials
Good Clinical Practice standards impact: the essential role of investigator capabilities
Related
- Navigating the Role of Clinical Pharmacists in Integrative Oncology Care Teams: Time to Create Higher Training and Practice Standards
- Intensity-modulated radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer: a single-institutional phase II investigator-initiated nonrandomized clinical trial
- Nearly one in five essential medicines fail quality standards in Africa: A systematic review and meta-analysis of MNCH medicines and antimalarials
- CIRSE Standards of Practice for the Use of Non-sclerosant Liquid Embolic Agents in IR Practice
- Optimizing the study planning phase in an investigator-initiated multicenter clinical trial: Mapping the process into a blueprint.
BibTeX
@article{peralta2026good,
title = {{Good Clinical Practice standards impact: the essential role of investigator capabilities}},
author = {Galo Peralta and Blanca Sánchez-Santiago},
journal = {Trials},
year = {2026},
month = nov,
doi = {10.1186/s13063-026-10082-1},
url = {https://link.springer.com/article/10.1186/s13063-026-10082-1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Good Clinical Practice standards impact: the essential role of investigator capabilities
AU - Galo Peralta
AU - Blanca Sánchez-Santiago
PY - 2026
DA - 2026/11/16
JO - Trials
DO - 10.1186/s13063-026-10082-1
UR - https://link.springer.com/article/10.1186/s13063-026-10082-1
SN - 1745-6215
ER -